Inventor · Paunzhausen, DE

Andreas Hohlbaum

22Patents
5h-index
31Co-inventors
65Inventor score

Filing activity: Nov 25, 2005 → Nov 5, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9260492B2 Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3) Chemistry; Metallurgy 20 Active
US9051382B2 Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such Chemistry; Metallurgy 18 Active
US7892827B2 Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4) Human Necessities 17 Active
US8313924B2 Muteins of tear lipocalin and methods for obtaining the same Physics 11 Active
US8986951B2 Tear lipocalin in muteins binding IL-4 R alpha Chemistry; Metallurgy 9 Active
US10046027B2 Muteins of tear lipocalin and methods for obtaining the same Physics 5 Active
US9687524B2 Tear lipocalin muteins binding IL-4 R alpha Chemistry; Metallurgy 5 Active
US9221885B2 Muteins of human lipocalin 2 with affinity for CTLA-4 Physics 4 Active
US10016483B2 Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors Human Necessities 4 Active
US9212208B2 Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same Physics 4 Active
US9221887B2 Muteins of tear lipocalin and methods for obtaining the same Physics 4 Active
US9572863B2 Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors Human Necessities 2 Active
US9610356B2 Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Physics 1 Active
US10232014B2 Tear lipocalin muteins binding IL-4 R alpha Chemistry; Metallurgy 1 Active
US10857202B2 Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors Human Necessities 1 Active
US10398754B2 Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors Human Necessities 1 Active
US9598476B2 Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9 Human Necessities 0 Active
US9150629B2 Human tear lipocalins which bind PCSK9 and methods of use thereof Human Necessities 0 Active
US9950034B2 Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Physics 0 Active
US9751920B2 Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same Physics 0 Active
US10898545B2 Tear lipocalin muteins binding IL-4 r alpha Chemistry; Metallurgy 0 Active
US11382951B2 Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.